Singapore is negotiating concessions for pharmaceutical exports to the U.S. while ensuring it still has access to high-end AI ...

Singapore's Ministry of Trade and Industry has cut the country's growth forecast for 2025 to zero percent to 2 percent in the ...

Inflation, which is already down to a four-year low, will remain modest amid weakening growth outlook Read more at ...

The party says that while it respects Singapore's concerns, it believes the country's reaction to the issue was "somewhat ...

Aster Chemicals and Energy, the new operator of the Bukom refining complex, is planning to bid for Exxon Mobil's petrol ...

Singapore is seeking concessions on pharmaceutical exports to the US, acknowledging that a 10% baseline tariff will not be ...

Singapore’s political leaders are warning against foreign attempts to influence voters in an election campaign, under ...

A weakened mandate for the People's Action Party government would make it harder for Singapore to advance its ...

It is expected to be almost similar with 2024’s S$29.3b. In a world that is fast changing with countries increasingly taking ...

U.S. tariffs will have multiplier effects that will "generate a broader negative income and demand shock to the Singapore ...

MOM expects the labour market to soften, given greater uncertainties in external growth prospects. Read more at ...

Singapore remains a powerhouse of opportunity, but it’s essential to walk in with open eyes and a well-calibrated strategy.